TradingMarkets 7 Stocks You Need To Know For Today
Genentech
(
DNA |
Quote |
Chart |
News |
PowerRating) and OSI Pharmaceuticals
(
OSIP |
Quote |
Chart |
News |
PowerRating)
said the FDA approved Tarceva in combination with gemcitabine chemotherapy as a
pancreatic cancer treatment.
Prudential
(
PRU |
Quote |
Chart |
News |
PowerRating) beat by 0.30, beat on revenues and
guided higher. Q3 profits more than doubled.
Wal-Mart’s
(
WMT |
Quote |
Chart |
News |
PowerRating) October same-store-sales rose
4.3%, more than expected. The company sees November sales up 3-5%, up from the
previous 2-4%.
Abercrombie & Fitch’s
(
ANF |
Quote |
Chart |
News |
PowerRating) October
same-store-sales surged 31%, beating estimates by a wide margin.
Becton Dickinson
(
BDX |
Quote |
Chart |
News |
PowerRating) beat estimates and raised
guidance
Priceline
(
PCLN |
Quote |
Chart |
News |
PowerRating) beat by .10. Travel bookings rose
40%.
Qualcomm
(
QCOM |
Quote |
Chart |
News |
PowerRating) missed by a penny but guided
higher. Sales were above expectations. The stock traded higher pre-open.